Rheumatology

Regional Health is involved in rheumatology research trials. Below is more information about the purpose and the name of the physician (principal investigator) for each trial. For more in-depth information on the research studies, click the blue title, which will lead you to the U.S. National Institute of Health website.


REFLECTIONS B537-02: Study of PF-06438179 (Infliximab-Pfizer) and Infliximab in Combination With Methotrexate in Subjects With Active Rheumatoid Arthritis.

PURPOSE: The study will assess the efficacy and safety of PF-06438179 and infliximab in combination with methotrexate in subjects with active rheumatoid arthritis who have had an inadequate response to methotrexate.

To learn more, contact:
Regional Health
Clinical Research
Email: Research
605-755-3982
 

CORRONA: The CORRONA Data Collection Program study is designed to systematically collect and document use patterns, effectiveness, and safety of DMARDs (Disease Modifying Anti-Rheumatic Drugs), biologic agents and any other treatments currently used in the management of Rheumatoid Arthritis (RA), Undifferentiated Arthritis (UA), Psoriatic Arthritis (PsA), and other rheumatic diseases.

Condition: Rheumatoid Arthritis

To learn more, contact:
Regional Health
Clinical Research
Email: Research
605-755-3982